Author:
Johnson-Davis Kamisha L.,Ly Diane
Reference11 articles.
1. Company ELa Zyprexa (olanzapine) package insert. https://www.bing.com/search?q=olanzapine+package+insert&form=ANNH01&refig=c97d02a6c6b4462b84c4ee31d4aa3beb&sp=11&lq=0&qs=EP&pq=olanzapine+package+&sc=10-19&cvid=c97d02a6c6b4462b84c4ee31d4aa3beb
2. Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1–02):9–62. https://doi.org/10.1055/s-0043-116492
3. Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C (2018) TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians. World J Biol Psychiatry 19(3):162–174. https://doi.org/10.1080/15622975.2018.1439595
4. Weigmann H, Härtter S, Maehrlein S, Kiefer W, Krämer G, Dannhardt G, Hiemke C (2001) Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 759(1):63–71. https://doi.org/10.1016/s0378-4347(01)00215-8
5. Olesen OV, Poulsen B, Linnet K (2001) Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring. Ther Drug Monit 23(1):51–55. https://doi.org/10.1097/00007691-200102000-00010